GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system.
Using structure based genome mining targeting vascular endothelial and platelet derived growth factor immunoglobulin (Ig) like folds, we have identified a sequence corresponding to a single transmembrane protein with two Ig domains, which we cloned from a human brain cDNA library. The cDNA is identical to hepatocyte cell adhesion molecule (hepaCAM), which was originally described as a tumor suppressor gene in liver. Here, we show that the protein is predominantly expressed in the mouse and human nervous system. In liver, the expression is very low in humans, and is not detected in mice. To identify the central nervous system (CNS) regions and cell types expressing the protein, we performed a LacZ reporter gene assay on heterozygous mice in which one copy of the gene encoding the novel protein had been replaced with beta-galactosidase. beta-galactosidase expression was prominent in white matter tracts of the CNS. Furthermore, expression was detected in ependymal cells of the brain ventricular zones and the central canal of the spinal cord. Double labeling experiments showed expression mainly in CNPase positive oligodendrocytes (OL). Since the protein is predominantly expressed in the CNS glial cells, we named the molecule glial cell adhesion molecule (GlialCAM). A potential role for GlialCAM in myelination was supported by its up-regulation during postnatal mouse brain development, where it was concomitantly expressed with myelin basic protein (MBP). In addition, in vitro, GlialCAM was observed in various developmental stages of OL and in astrocytes in processes and at cell contact sites. In A2B5 positive OL, GlialCAM colocalizes with GAP43 in OL growth cone like structures. Overall, the data presented here indicate a potential function for GlialCAM in glial cell biology.
Favre-Kontula
Linda
L
Protein and Cell Sciences, Merck Serono, Geneva Research Center, Geneva, Switzerland.
Rolland
Alexandre
A
Bernasconi
Lilia
L
Karmirantzou
Maria
M
Power
Christine
C
Antonsson
Bruno
B
Boschert
Ursula
U
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000378:metabolism; D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D015815:Cell Adhesion Molecules / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D019062:Cell Adhesion Molecules, Neuron-Glia / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D002490:Central Nervous System / Q000166:cytology*; D003001:Cloning, Molecular; D019922:GAP-43 Protein / Q000378:metabolism; D005732:Gangliosides / Q000378:metabolism; D015870:Gene Expression / Q000502:physiology*; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D004676:Myelin Basic Protein / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D009457:Neuroglia / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D015815:Cell Adhesion Molecules; D019062:Cell Adhesion Molecules, Neuron-Glia; D019922:GAP-43 Protein; D005732:Gangliosides; C000593181:GlialCAM protein, mouse; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; C062875:ganglioside A2B5; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases